SCHEMBL9404138

SCHEMBL9404138

CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@]3(O)CCOC(=O)O)[C@H]12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 6/20 0.62
LMNA P02545 3/20 0.62
CYP3A4 P08684 1/20 0.62
NFKB1 P19838 1/20 0.62
HIF1A Q16665 1/20 0.62
ABCB11 O95342 1/20 0.62
ESR1 P03372 1/20 0.62
NR3C1 P04150 1/20 0.62
PGR P06401 1/20 0.62
CHRM2 P08172 1/20 0.62
ABCB1 P08183 1/20 0.62
NR3C2 P08235 1/20 0.62
CYP2C19 P33261 1/20 0.62
ADRA1A P35348 1/20 0.62
OPRK1 P41145 1/20 0.62
HTR2B P41595 1/20 0.62
ESR2 Q92731 1/20 0.62
SLC47A1 Q96FL8 1/20 0.62
RAB9A P51151 1/20 0.62
MAPT P10636 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7787111 1.00 AR (0.62) ARLMNACYP3A4NFKB1HIF1A
SCHEMBL11646422 0.89 AR (0.61) ARLMNACYP3A4NFKB1HIF1A
SCHEMBL11646428 0.89 AR (0.61) ARLMNACYP3A4NFKB1HIF1A
SCHEMBL5296168 0.89 AR (0.65) ARLMNACYP3A4NFKB1HIF1A
SCHEMBL8846916 0.89 AR (0.65) ARLMNACYP3A4NFKB1HIF1A
SCHEMBL259433 0.89 AR (0.65) ARLMNACYP3A4NFKB1HIF1A
SCHEMBL259434 0.89 AR (0.65) ARLMNACYP3A4NFKB1HIF1A
SCHEMBL8846925 0.89 AR (0.65) ARLMNACYP3A4NFKB1HIF1A
SCHEMBL18812341 0.88 LMNA (0.66) ARLMNACYP3A4NFKB1HIF1A
SCHEMBL11644576 0.87 LMNA (0.65) ARLMNACYP3A4NFKB1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0610357-A1 TRANSDERMAL THERAPEUTIC SYSTEMS CONTAINING CRYSTALLIZATION INHIBITORS. SCHERING AG (DE) 1994-08-17 EP disclosed
WO-1993008795-A1 TRANSDERMAL THERAPEUTIC SYSTEMS CONTAINING CRYSTALLIZATION INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 1993-05-13 WO disclosed